H19 and acute lymphoblastic leukemia: Expression of H19 decreased by (0.24-fold, P<0.05) and(0.4-fold, P<0.05) in the Jurkat and RPMI-8402 cells, and (0.22- fold,P<0.05) and (0.29-fold, P<0.01) in the Daudi and Ramous cells, respectively.Treatment with ASP caused an insignificant downregulation of H19expression in the ALL cell lines, with the exception of the Daudi cells (Fig .2E, F).